Menu

Neuroscientist and Champion of Glia Research Dies

Ben Barres of Stanford University described glia’s roles in ensuring neurons’ proper synapse formation and in responding to brain injury.

Dec 28, 2017
Kerry Grens

YOUTUBE, WORLDVIEW STANFORDStanford University neuroscientist Ben Barres, whose studies of glial cells documented their fundamental importance in the brain, died yesterday (December 27) of pancreatic cancer. He was 63 years old.

Barres is renowned for putting glia on the neuroscience map. Where once these cells where considered background support for neurons, Barres and his colleagues established their essential role in synapse formation and in response to acute injury in the brain.

“If you took the Barres lab out of the field of glial studies, there would be no field,” Martin Raff, a neuroscientist at University College London where Barres did his postdoc, says in a press release.

While an undergraduate at MIT, Barres took a course on the brain that inspired him to study the organ—both as a physician and researcher. First, he earned a medical degree from Dartmouth Medical School; then, while working part time as a neurologist, he completed a PhD in David Corey’s lab at Harvard University. “Although my plan was to simultaneously practice and do research, I was much more aware after my residency that there was very little that neurologists could do to help their patients,” Barres told The Scientist earlier this year.

See “Glia Guru,” a profile of Ben Barres

It was in Corey’s lab that Barres began to elevate the profile of glia. He showed they had ion channels and developed a cell-sorting technique called panning that uses antibodies to isolate glia. In Raff’s lab, Barres purified different types of glia using the technique and began to explore their functions.

In 1993, Barres established his own lab at Stanford University, where he demonstrated that glia are critical for neurons’ synapse formation, first in culture and then in vivo. “That was a complete surprise,” Barres told The Scientist. “The dogma was that neurons intrinsically have all of the machinery to form synapses.” Barres went on to refine his panning technique to purify mature astrocytes, a type of glial cell, from animals’ brains, revealing their role in synaptic pruning.

“It’s been really like taking candy from a baby,” Barres told The Scientist in 2015. “As soon as you can purify the cells and culture them, you can start to gene profile them and start to understand what genes are unique, and that gives you clues immediately about their function.”

In the mid-1990s, Barres transitioned from female to male. He was open about his transition with his colleagues, and made a point to be open about being gay to serve as a role model for students and younger scientists. “Yes, there’s going to be an occasional person who may not talk to you as much,” Barres told The Scientist in 2010, “but the vast, vast proportion of scientists are very supportive of differences.”

More recently, Barres studied the role of glia in responding to injury and in neurodegeneration. Earlier this year, for instance, his group reported that rogue astrocytes can cause other glia and neurons to die. By this point, Barres had already been dealing with pancreatic cancer for a year. Knowing he would soon pass, Barres spent his last days preparing letters of recommendation for his trainees.

“He had a selfless, outward-looking focus,” Stanford’s Thomas Clandinin says in the press release. “I’ve gone a lot of places in the months since Ben was diagnosed, and I haven’t gone anywhere yet where someone hasn’t come up to me and asked me about how Ben was doing. Every one of them has a story about how he helped them in their career.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!